08
May

Merck picked up FDA approval for the clot-busting cardio drug vorapaxar, a treatment once billed as a potential warfarin successor before running into some alarming safety issues.

…read more

Source: Merck wins FDA approval for a once-vaunted cardio drug

    

0 No comments